Date de publication: 5 septembre 2017
Promoteur – Intermédiaire Financier
HUVEPHARMA INTERNATIONAL BV
The project consists of the construction of new manufacturing facilities, as well as financing of the promoter's research, development and innovation (RDI) activities.
The EIB loan will be supporting the capacity expansion of a mid-cap company in Bulgaria.
- Industrie - Industrie manufacturière
Montant BEI envisagé (montant approximatif)
EUR 125 million
Coût total (montant approximatif)
EUR 212 million
The project falls under Annex II of EIA Directive 2011/92/EU (implementation of an industrial facility for the production of pharmaceutical products). Full environmental details will be assessed during the appraisal.
Passation des marchés
The promoter is a private company not operating in the utilities sector and is thus not covered by EU directives on procurement.
Signé - 22/12/2017
Clause de non-responsabilité
Before financing approval by the Board of Directors, and before loan signature, projects are under appraisal and negotiation. The data provided on this page is therefore indicative and cannot be considered to represent official EIB policy (see also the Explanatory notes).